Trial Profile
Once- versus twice-daily everolimus for the prevention of rejection in liver transplant recipients also taking tacrolimus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Pharmacokinetics
- 11 Sep 2013 Results presented at the 16th Congress of the European Society for Organ Transplantation.
- 22 Aug 2013 New trial record